DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to Potential for False Negatives and Underreporting of Viral Infection

Saved in:
Bibliographic Details
Published in:Clinical Chemistry 2021-02, Vol.67 (2), p.435-437
Main Author: Rosebrock, Adam P
Format: Article
Language:English
Subjects:
Centers for Disease Control and Prevention, U.S
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 - virology
COVID-19 Testing
Cross Reactions
Cross-reactivity
Disease control
DNA, Viral - chemistry
Epidemiology
False Negative Reactions
Humans
Letters to the Editor
Pandemics
Polymerase Chain Reaction - methods
SARS-CoV-2 - genetics
Severe acute respiratory syndrome coronavirus 2
United States
Viral diseases
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0009-9147
1530-8561
DOI:10.1093/clinchem/hvaa284